2014-03-14T10:47:41-05:00 2013-06-30 941254756 HOOD & STRONG LLP 100 FIRST STREET 14TH FLOOR SAN FRANCISCO CA 94105 990 2012-07-01 030485196 MYELIN REPAIR FOUNDATION MYEL 4088712410 18809 COX AVENUE NO 190 SARATOGA CA 95070 DENISE ST ONGE 4088712410 2014-03-06 1 MAGA E KISRIEV P01008919 4157810793 2012 2015-11-30 17:44:51Z SCOTT JOHNSON 18809 COX AVENUE NO 190 SARATOGA CA 95070 6423567 0 X WWW.MYELINREPAIR.ORG X 2002 CA THE FOUNDATION IS DEDICATED TO DEVELOPING MYELIN REPAIR TREATMENTS FOR MULTIPLE SCLEROSIS. 6 5 13 20 0 0 1761904 4428671 0 0 7382 -12114 13771 -37000 1783057 4379557 2400000 1749400 0 0 1584307 1891625 0 0 939971 2028890 1857400 6013197 5498425 -4230140 -1118868 8436907 7317764 575288 575013 7861619 6742751 X THE MYELIN REPAIR FOUNDATION GRANTS FUNDS FOR RESEARCH TO DEVELOP RATIONAL DRUG TARGETS TO SLOW, STOP, AND ULTIMATELY REPAIR DAMAGE TO MYELIN CAUSED BY MULTIPLE SCLEROSIS. THE FOUNDATION HAS A DEFINED PROCESS FOR COLLABORATION AMONG SCIENTISTS AND WITH BUSINESSES THAT SUBSTANTIALLY SHORTENS THE TIME TO DISCOVERY OF THE MECHANISMS FOR MYELIN REPAIR AS WELL AS THE TIME TO COMMERCIALIZE THESE MECHANISMS IN THE FORM OF TREATMENTS FOR MS PATIENTS. 0 0 4138299 1749400 0 MRF PARTNERED WITH A PREMIER MS PHARMACEUTICAL COMPANY, BIOGEN IDEC, TO LICENSE ONE OF OUR NOVEL MOUSE MODELS TO SUPPORT BIOGEN'S MYELIN REPAIR THERAPEUTICS DEVELOPMENT PROGRAM.MRF RECEIVED THEIR 9TH PATENT FOR MYELIN REPAIR TECHNOLOGY IN APRIL 2013.THROUGH MRF'S TARGETED DISCOVERY BIOLOGY MRF FUNDED 40 PI'S AND RESEARCHERS. THE MRF CONSORTIUM IS IN ITS 10TH YEAR OF FUNDING TARGETED RESEARCH FOCUSED ON MYELIN REPAIR. 4138299 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 24 0 13 1 0 0 0 0 0 0 0 0 0 0 X 6 5 0 0 0 0 0 0 0 1 1 0 0 1 1 0 0 0 0 1 1 0 CA X SCOTT JOHNSON 4088712410 18809 COX AVENUE 190 SARATOGA CA 95070 SCOTT JOHNSON 40.00 X X 266673 0 38063 JIM GIDWITZ 1.00 X 0 0 0 SHARON WIENBAR 1.00 X 0 0 0 CASEY MCGLYNN 1.00 X 0 0 0 ANDY CATES 1.00 X 0 0 0 BOBBY MEHTA 1.00 X 0 0 0 JAY TUNG 40.00 X 199550 0 37147 DENISE ST ONGE 15.00 X 38350 0 0 TASSIE COLLINS 40.00 X 177400 0 10856 JASON DUGAS 40.00 X 122300 0 17189 804273 0 103255 4 0 1 0 WILSON SONSINI GOODRICH AND ROSATI 650 PAGE MILL ROAD PALO ALTO CA 94304 PATENT AND LEGAL SERVICES 554577 MIKE PLEISS AND ASSOCIATES LLC 848 STELLA COURT SUNNYVALE CA 94087 RESEARCH CONSULTING 141600 2 256100 4172571 1987510 4428671 4420 4420 1970976 1987510 -16534 -16534 -16534 19500 256100 56500 -37000 -37000 4379557 0 0 -49114 1689400 1689400 60000 60000 726365 517473 59191 149701 865550 307934 112413 445203 184688 45937 42916 95835 115022 54126 19960 40936 369499 293606 25830 50063 107343 107343 9042 9042 45181 18693 8951 17537 39680 7294 1548 30838 262841 177918 31218 53705 101370 60893 3287 37190 207019 204541 2478 17025 14557 867 1601 8631 3480 1810 3341 PATENT EXPENSES 493640 493640 TRANSLATIONAL MED LAB 157340 157340 DRUG TARGET VALIDATION 29342 29342 9447 2125 4821 2501 5498425 4138299 420155 939971 47 0 5676517 4988116 2682033 2204410 6035 26521 88383 24576 48065 63807 24210 34910 8436907 7317764 340288 433946 235000 141067 575288 575013 X 5179586 4190341 2682033 2552410 7861619 6742751 8436907 7317764 -1118868 0 X 0 1 X 1 0 X 7112757 12165768 1528919 1761904 4428671 26998019 7112757 12165768 1528919 1761904 4428671 26998019 15411120 11586899 36144 10978 26870 7382 4420 85794 90035 76500 23960 67204 19500 277199 27361012 0.42350 0.42320 X SCHEDULE A, PART IV, LIST OF UNUSUAL GRANTS: BEQUEST DATE: 01/11/13 AMOUNT: 1999996. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 41846 2732 39114 46537 21844 24693 63807 X 4617385 181328 181328 4436057 -56500 -56500 4379557 5736253 181328 56500 237828 5498425 0 5498425 DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X, LINE 2: THE FOUNDATION IS EXEMPT FROM FEDERAL INCOME AND CALIFORNIA FRANCHISE TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND SECTION 23701(D) OF THE CALIFORNIA REVENUE AND TAXATION CODE, RESPECTIVELY. ADDITIONALLY, THE FOUNDATION HAS BEEN DETERMINED BY THE INTERNAL REVENUE SERVICE NOT TO BE A PRIVATE FOUNDATION WITHIN THE MEANING OF SECTION 509(A) OF THE INTERNAL REVENUE CODE. THE FOUNDATION FOLLOWS FINANCIAL ACCOUNTING STANDARDS BOARD'S ACCOUNTING STANDARDS CODIFICATION TOPIC 740 INCOME TAXES TO ACCOUNT FOR UNCERTAIN TAX POSITIONS. MANAGEMENT HAS CONCLUDED THAT THE FOUNDATION HAS TAKEN NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE ADJUSTMENT TO THE FINANCIAL STATEMENTS TO COMPLY WITH PROVISIONS OF THIS GUIDANCE. THE FOUNDATION IS GENERALLY NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY FEDERAL AND STATE TAX AUTHORITIES FOR YEARS PRIOR TO 2009 AND 2008, RESPECTIVELY. PART XI, LINE 4B - OTHER ADJUSTMENTS: SPECIAL EVENTS EXPENSE -56,500. PART XII, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENTS EXPENSE 56,500. 1 EAST ASIA AND THE PACIFIC - 0 0 PROGRAM SERVICES SPONSORED RESEARCH 60000 0 0 0 0 0 0 60000 0 60000 AUSTRALIA SPONSORED RESEARCH 60000 1 0 0 0 0 0 0 0 PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.: SCHEDULE F, PART I, LINE 2: THE RESEARCHER IS SUBECT TO TERMS AND CONDITIONS OF THE SPONSORED RESEARCH AGREEMENT BETWEEN THE UNIVERSITY AND THE MRF. THE RESEARCHER'S WORK IS REVIEWED BY THE SCIENTIFIC ADVISORY BOARD AND BY THE MRF RESEARCH AND DEVELOPMENT STAFF. GOLF TOURNAMENT 275600 256100 19500 9920 14165 32415 275600 256100 19500 9920 14165 32415 56500 -37000 1 CASE WESTERN RESERVE UNIVERSITY 2109 ADELBERT ROAD CLEVELAND OH 44106 341018992 501(C)(3) 404400 MYELIN RESEARCH STANFORD UNIVERSITY FAIRCHILD BLDG RM D201A 200 CAMPUS DRIVE STANFORD CA 94305 941156365 501(C)(3) 420000 MYELIN RESEARCH UNIVERSITY OF CHICAGO 5841 S MARYLAND AVE CHICAGO IL 60637 362177139 501(C)(3) 420000 MYELIN RESEARCH NORTHWESTERN UNIVERSITY 710 N LAKE SHORE DR CHICAGO IL 60611 362167817 501(C)(3) 300000 MYELIN RESEARCH NATIONAL INSTITUTES OF HEALTH 31 CENTER DRIVE BESTHEDA MD 20892 521986675 501(C)(3) 75000 MYELIN RESEARCH UNIVERSITY OF CALIFORNIA SAN FRANCISCO 1855 FOLSOM ST MCB 425 SAN FRANCISCO CA 94143 941550853 501(C)(3) 70000 MYELIN RESEARCH 6 0 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: THE VP OF DRUG DISCOVERY CAREFULLY REVIEWS EACH AWARD AND RESEARCH CONTRACT TO ENSURE COMPLIANCE WITH ALL FINANCIAL AND PROGRAMMATIC PROVISIONS. X X X X 0 0 0 0 0 0 0 0 0 SCOTT JOHNSON 241673 0 25000 0 0 0 0 0 38063 0 304736 0 0 0 JAY TUNG 179550 0 20000 0 0 0 0 0 37147 0 236697 0 0 0 TASSIE COLLINS 162400 0 15000 0 0 0 0 0 10856 0 188256 0 0 0 X 1 1987510 FAIR MARKET VALUE 0 0 0 METHOD FOR DETERMINING NUMBER OF CONTRIBUTIONS: PART I, COLUMN (B): THE NUMBER OF CONTRIBUTIONS REFLECTS THE NUMBER OF DONORS, NOT THE NUMBER OF ITEMS DONATED. FORM 990, PART VI, SECTION B, LINE 11 THE TAXPAYER'S ACCOUNTING FIRM FORWARDED THE FORM 990 TO THE CFO WHO THEN FORWARDED THE FORM 990 TO THE BOARD MEMBERS FOR THEIR REVIEW PRIOR TO FILING THE FORM 990. BOARD MEMBERS WERE ENCOURAGED TO REVIEW THE FORM AND TO FORWARD THEIR QUESTIONS, IF ANY, TO THE CFO. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION COMMITTEE, WHICH IS COMPOSED OF THREE OF THE INDEPENDENT DIRECTORS, MUST REVIEW AND APPROVE ALL MANAGEMENT COMPENSATION. FORM 990, PART VI, SECTION C, LINE 19 FINANCIAL STATEMENTS ARE LINKED TO THE WEBSITE. CONFLICT OF INTEREST POLICY AND GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST.